Aenova
is the company formed by the merger of two separate investments made by Bridgepoint: Swiss Caps, Europe’s No 2 contract soft capsule manufacturer of vitamins, minerals, supplements and pharma products, and Dragenopharm, a German contract manufacturer for the generic prescription drugs market.Investment overview
| Sector | Pays | Acquisitions | Valeur de l'opération |
|---|---|---|---|
| Healthcare | Germany | 2005 | N/D |
Formed in 2008, Aenova created the number one European contract pharma company in solid and soft capsule dosage forms by revenue and range of activities. Combining both businesses creates the opportunity to improve manufacturing efficiency, and through sharing technological know-how, accelerate both product development and expansion of its customer base. To learn more about the company, visit http://www.aenova.de